PHIO · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2022-08-11 compared with 2022-05-12 · 4 added, 2 removed, 19 unchanged (24% of the section changed)
2 unchanged sentences
Incorporated by Reference Herein
+Added: Amended and Restated Bylaws of Phio Pharmaceuticals Corp.
+Added: Current Report on Form 8-K (File No.
Sarbanes-Oxley Act Section 302 Certification of Principal Executive Officer and Principal Financial Officer.
14 unchanged sentences
Geert Cauwenbergh, Dr.
−Removed: Principal Executive and
−Removed: Financial Officer, Director
+Added: Principal Executive and Financial Officer, Director
+Added: August 11, 2022
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.